TORONTO, Aug. 30, 2016 /CNW/ - The Myeloma Canada Research Network (MCRN) is proud to launch the MCRN Canadian Multiple Myeloma Database – a nationwide, multi-centre, initiative that will be a cornerstone to optimizing clinical outcomes using evidence-based decision making for the treatment and care of patients and to inform myeloma research, clinical trial development, and sound health policies for Canadian cancer patients.
Photo & Interview Opportunities: Hematology experts, Canadians living with multiple myeloma, healthcare stakeholders and valued supporters will gather for a launch event to discuss the need, role and use of the new MCRN Canadian Multiple Myeloma Database.
Date: Thursday, September 1
Time: 8 a.m. to 9:30 a.m. (breakfast will be served)
Location: MaRS Discovery District, Room CR3. 101 College Street, Toronto, ON
- Dr. Chris Venner, Chair, MCRN Canadian Multiple Myeloma Database and clinical lead for the Malignant Hematology Program at the Cross Cancer Institute, Edmonton
- Dr. Donna Reece, Director of Program for Multiple Myeloma and Related Diseases at Princess Margaret Cancer Centre, Toronto
- Aldo Del Col, Co-Founder and Chairman, Myeloma Canada and Myeloma Canada Research Network
About the Myeloma Canada Research Network (MCRN)
The MCRN is the first and only national academic myeloma research group bringing together Canada's leading myeloma investigators from 20 centres across the country. Focusing on high-impact Phase I and II clinical trials, the MCRN brings meaningful value through its network of internationally recognized investigators who are willing to share their expertise in leading-edge myeloma research and technologies to identify new treatments and make them available through its member institutions located in both large urban and smaller communities across Canada.
About Myeloma Canada
Myeloma Canada is a non-profit, grassroots, patient-focused organization created by, and for, people living with multiple myeloma. As the only national organization exclusively devoted to the Canadian myeloma community, Myeloma Canada has been making myeloma matter since 2005. Myeloma Canada seeks to strengthen the voice of the Canadian myeloma community by working with leading myeloma researchers and clinicians, local support groups and other cancer organizations to improve the quality of life of myeloma patients, their caregivers and their families through education, awareness, advocacy and research. www.myeloma.ca
SOURCE Myeloma Canada
Image with caption: "Myeloma Canada Research Network (MCRN) (CNW Group/Myeloma Canada)". Image available at: http://photos.newswire.ca/images/download/20160830_C5374_PHOTO_EN_759979.jpg
For further information: confirm your attendance and or request an interview, please contact: Rob McEwan, Argyle Public Relationships, firstname.lastname@example.org, 416-968-7311 ext. 242; Chriselle D'Souza, Argyle Public Relationships, CDSouza@argylepr.com, 416-968-7311 ext. 246